Codes to use when billing for Neuspera’s integrated SNM device
“It is common for a payer to request patient records when submitting for a service with a category III code,” write Jonathan Rubenstein, MD, and Mark Painter.
Related Articles
Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD
Canes describes the challenges of modern urology practice, from the deluge of portal messages to the variability in how clinicians deliver pre- and post-visit instructions
How to register for EMUC23
All information about registration for the 15th European Multidisciplinary Congress on Urological Cancers (EMUC23).
Sandip Prasad, MD, on the approval of mitomycin intravesical solution for LG-IR-NMIBC
Sandip M. Prasad, MD, MPhil, shares his thoughts on the impact of the FDA approval of mitomycin for intravesical solution for patients with LG-IR-NMIBC.
MANAGEMENT OF ERECTILE DYSFUNCTION – Uroweb
The EAU Sexual and Reproductive Health Guidelines aim to provide a overview of the aspects relating to sexual and reproductive health in adult males.
Celebrating 50 years of Advancing Urologic Research – American Urological Association
A Legacy of Impact: Since 1975, nearly $40 million dollars has been awarded to over 1,000 urology physician scientists and researchers spanning the entire career…
FDA grants priority review to gepotidacin for uncomplicated urogenital gonorrhea
The target action date for the application is December 11, 2025.
A viable alternative in prostate enucleation: PlasmaLEP
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Editorial Comment | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Cognitive Function in Kidney Transplant Recipients Better With Extended-Release Tacrolimus – Renal and Urology News
A post-marketing study assessed tacrolimus-induced cognitive impairment among kidney transplant recipients who switched drug formulations.
